Literature DB >> 1314085

Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.

M E Rafestin-Oblin1, M Lombes, B Couette, E E Baulieu.   

Abstract

We have previously reported that mineralocorticosteroid receptor (MR) is a 8-9 S heterooligomeric complex that includes the 90 kDa heat shock protein (hsp90). To elucidate how antagonist-receptor complexes are biologically inactive in terms of transcriptional regulation, we analyzed the binding of mineralocorticosteroid agonists and antagonists with MR and the ligand-induced transformation of its heterooligomeric structure. This study was performed in the cytosol of adrenalectomized rat kidney and of COS cells transiently transfected with human MR cDNA. Although aldosterone antagonists (SC9420 and RU26752) bind MR with the same affinity as aldosterone, they dissociate much more rapidly from the 8-9 S form of both rat and human MR than does aldosterone. Using sedimentation gradient analysis, we showed that the interaction between hsp90 and the steroid binding subunit of MR is highly dependent upon the nature of the steroid ligand since the binding of aldosterone antagonists results in an easy release of hsp90. We propose that both rapid dissociation of ligand and weakened hsp90-receptor interaction play a key role in the mechanism of mineralocorticosteroid antagonism. In the COS cell model, cortisol, described as a weak mineralocorticosteroid agonist, dissociates also more rapidly from human MR than does aldosterone. Our results suggest that ligand binding kinetics and ligand dependent modification in receptor structure are important modulators of MR function as a transcriptional regulatory factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314085     DOI: 10.1016/0960-0760(92)90430-q

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  11 in total

1.  Differential effects of mineralocorticoid blockade on the hypothalamo-pituitary-adrenal axis in pregnant and nonpregnant ewes.

Authors:  Melissa Lingis; Elaine M Richards; Maureen Keller-Wood
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-01-04       Impact factor: 4.310

2.  Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells.

Authors:  G Schulman; R Lindemeyer; A Barman; S Karnik; C P Bastl
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Transcriptional control of sodium transport in tight epithelial by adrenal steroids.

Authors:  F Verrey
Journal:  J Membr Biol       Date:  1995-03       Impact factor: 1.843

4.  The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase.

Authors:  J W Funder
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 5.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

Review 6.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

7.  The N-terminal adenosine triphosphate binding domain of Hsp90 is necessary and sufficient for interaction with estrogen receptor.

Authors:  L Bouhouche-Chatelier; A Chadli; M G Catelli
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

8.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

9.  Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements.

Authors:  M Lombès; N Binart; M E Oblin; V Joulin; E E Baulieu
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

10.  Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.

Authors:  M Lombès; N Binart; F Delahaye; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.